Dasatinib-induced hypoglycemia in a patient with acute lymphoblastic leukemia. Journal Article


Authors: Lundholm, MD; Charnogursky, GA
Article Title: Dasatinib-induced hypoglycemia in a patient with acute lymphoblastic leukemia.
Abstract: Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
Journal Title: Clinical case reports
Publisher: Unknown  
Date Published: 2020